Efficacy of docetaxel concurrent chemoradiotherapy for esophageal carcinoma

Machine translation Machine translation
Authors Yang, Zhenhua -More
Category Primary study
Journal赣南医学院学报 (Journal of Gannan Medical College)
Year 2008
Links DOI
Esophageal cancer is a common clinical malignancy, radiation therapy is an important means of treatment of esophageal cancer, but a higher rate of local recurrence radiotherapy, chemotherapy sensitizers may reduce the local recurrence rate and improved 5-year survival rate. Docetaxel is a higher activity of anticancer drugs, with sensitizing effect. hospital treatment of esophageal cancer using this method to obtain better results.
This translation has been produced by an automated software. If you wish to submit your own translation, please send it to translations@epistemonikos.org
Epistemonikos ID: 4e1bcb1ded236b39c90719f373363be46cc3d10d
First added on: Jun 24, 2013
Warning
This is a machine translation from an article in Epistemonikos.

Machine translations cannot be considered reliable in order to make health decisions.

See an official translation in the following languages: 中文

If you prefer to see the machine translation we assume you accept our terms of use